• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic

What diabetes tech companies are doing on World Diabetes Day 2024

November 14, 2024 By Sean Whooley

World Diabetes day

World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]

Filed Under: Diabetes, Drug-Device Combinations, Featured Tagged With: abbott, Ascensia Diabetes Care, Dexcom, embecta, Fresenius Medical Care, Insulet, Medtronic, National Diabetes Awareness Month 2024, World Diabetes Day 2024

Medtronic kicks off Blue Balloon Challenge for National Diabetes Awareness Month

November 1, 2024 By Sean Whooley

Geoff Martha Medtronic Blue Balloon Challenge 2024

Medtronic (NYSE:MDT) is kicking off another year of its Blue Balloon Challenge in recognition of National Diabetes Awareness Month. Introduced in 2021, the movement encourages people with diabetes to help drive awareness and understanding of the chronic condition. The company instructs people to take a video or photo while bouncing a blue balloon in the […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Medtronic, National Diabetes Awareness Month 2024, World Diabetes Day 2024

FDA approves IDE for Medtronic Prevail drug-coated balloon

October 23, 2024 By Sean Whooley

Medtronic logo updated

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB). The medtech giant can now begin a pivotal clinical trial for the coronary paclitaxel DCB for in-stent restenosis (ISR) and de novo small vessel disease. It plans to use data from its Prevail Global Clinical Program […]

Filed Under: Cardiovascular, Drug-Device Combinations, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: FDA, Medtronic

Medtronic recalls some MiniMed automated insulin delivery systems with battery issues

October 4, 2024 By Sean Whooley

Medtronic MiniMed 780G with Guardian 4 sensor

Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin pumps. FDA deemed the recall Class I, the most serious kind. The medtech giant issued a field action starting on July 31, notifying customers to follow built-in alerts for battery status. Customers should contact Medtronic if […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Recalls, Regulatory/Compliance, Technology Tagged With: FDA, Medtronic

The 9 largest diabetes technology companies in the world

August 21, 2024 By Sean Whooley

9 largest diabetes companies in the world abbott dexcom medtronic insulet

Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Dexcom, embecta, Insulet, Medtronic, Roche Diabetes Care, Senseonics, Tandem Diabetes Care, Ypsomed

Medtronic wants to be No. 1 in automated insulin delivery as Q1 results highlight Diabetes growth

August 20, 2024 By Sean Whooley

Medtronic MiniMed 780G automated insulin delivery system with Simplera Sync CGM Sensor

Medtronic (NYSE:MDT) reported more growth in its Diabetes unit as the company’s recent moves signal its intent in the competitive insulin pump market. The company’s first-quarter (fiscal 2025) results included $647 million in revenue from the Diabetes unit. That marked 11% year-over-year growth from the same three-month period a year ago. U.S. revenues grew in […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Medtronic wins FDA nod for next-gen Simplera CGM

August 7, 2024 By Sean Whooley

Medtronic InPen Simplera

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Simplera continuous glucose monitor (CGM). It marks another boost for Medtronic’s CGM portfolio, which will also include an integrated CGM offering through a collaboration with Abbott announced today. Simplera, the company’s first disposable, all-in-one CGM, comes in at half the size of previous Medtronic […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Regulatory/Compliance, Technology Tagged With: FDA, Medtronic

Abbott, Medtronic partner to connect CGM, insulin delivery systems

August 7, 2024 By Sean Whooley

Abbott FreeStyle Libre 2 Medtronic MiniMed 780G

Abbott (NYSE:ABT) and Medtronic (NYSE:MDT) today announced a global partnership pairing Abbott CGMs with Medtronic insulin delivery systems. The partnership aims to collaborate on a system based on Abbott’s FreeStyle Libre continuous glucose monitors (CGMs) with Medtronic’s automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Medtronic

The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions

June 25, 2024 By Sean Whooley

ADA 2024 Product Images Dexcom Abbott Senseonics Ascensia Insulet Tandem Medtronic Sequel

The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech. Topics covered included expanding technologies to the type 2 diabetes population (90% of people with diabetes), GLP-1 drugs, automation, broadening user bases and more. The usual big-hitters stepped up to the plate […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Pharmaceuticals, Technology Tagged With: abbott, Dexcom, embecta, Insulet, mannkind, Medtronic, Senseonics, Sequel Med Tech, Tandem Diabetes Care

How Medtronic developed its latest automated insulin delivery systems

June 25, 2024 By Sean Whooley

Medtronic MiniMed 780G with Guardian 4 sensor

In 2011, Lou Lintereur says Medtronic began “getting more serious” about commercializing automated insulin delivery technology. This process started out simply and built up to the closed-loop technologies we know today, like the MiniMed 780G. However, in order to get there, the company needed engineers with a background in control systems. Lintereur, the company’s chief engineer […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Medtronic

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 28
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS